Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Georgia Karadima is active.

Publication


Featured researches published by Georgia Karadima.


American Journal of Medical Genetics | 1998

Association between the GABAA receptor α5 subunit gene locus (GABRA5) and bipolar affective disorder

George N. Papadimitriou; Dimitris Dikeos; Georgia Karadima; Dimitrios Avramopoulos; Eugenia Daskalopoulou; Demetris Vassilopoulos; Costas N. Stefanis

Genetic factors seem to play an important role in the pathogenesis of affective disorder. The candidate gene strategies are being used, among others, to identify the genes conferring vulnerability to the disease. The genes coding for the receptors of gamma-aminobutyric acid (GABA) have been proposed as candidates for affective disorder, since the GABA neurotransmitter system has been implicated in the pathogenesis of the illness. We examined the possible genetic association between the GABAA receptor α5 subunit gene locus (GABRA5) on chromosome 15 and affective disorder, in 48 bipolar patients (BP), 40 unipolar patients (UP), and 50 healthy individuals, age- and sex-matched to the patients. All patients and controls were unrelated Greeks. Diagnoses were made after direct interviews according to the DSM-IV and ICD-10 criteria. For the genotyping, a dinucleotide (CA) repeat marker was used. The polymerase chain reaction (PCR) products found were nine alleles with lengths between 272 and 290 base pairs (bp). The distribution of allelic frequencies of the GABRA5 locus differed significantly between BP patients and controls with the 282-bp allele found to be associated with BP affective disorder, while no such difference was observed between the groups of UP patients and controls nor between the two patient groups. The presence or absence of the 282-bp allele in the genotype of BP patients was not shown to influence the age of onset and the overall clinical severity, but was found to be associated with a preponderance of manic over depressive episodes in the course of the illness. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 81:73–80, 1998.


Clinical Genetics | 2008

Apolipoprotein E polymorphism in the Greek population

Ekaterini Sklavounou; Effrosini Economou-Petersen; Georgia Karadima; Marios Panas; Dimitris Avramopoulos; Angeliki Varsou; Dimitris Vassilopoulos; Michael B. Petersen

The APOE gene is located on chromosome 19, and the three common alleles are designated ε2, ε3, and ε4. The ε4 allele is associated with increased plasma cholesterol, atherosclerosis and cardiovascular disease, Alzheimers disease, and decreased longevity. The objective of the present study was to estimate the distribution of APOE alleles in the Greek population by DNA analysis. The material consisted of 216 voluntary, healthy Greek blood donors (146 males/70 females). The APOE allele frequencies were ε2: 5.3%, ε3: 88.2%, ε4: 6.5%. The ε4 allele frequency of 6.5% in the Greek population is, together with the frequency in the Chinese population, among the lowest in the world.


Journal of Neurology | 1999

Apolipoprotein E and presenilin-1 genotypes in Huntington's disease

Marios Panas; Dimitrios Avramopoulos; Georgia Karadima; Michael B. Petersen; Demetrios Vassilopoulos

Abstract Huntington’s disease (HD) is an autosomal dominant degenerative disease of the central nervous system manifested by involuntary movements (chorea), psychiatric manifestations, and cognitive impairment with a variable age at onset. This variability is mainly attributed to genetic factors. The so-called aging genes [e.g., those for apolipoprotein E (APOE) and presenilin-1 (PS-1) have been implicated in determining the age at onset of Alzheimer’s disease, a disease sharing common clinical features with HD. In 60 unrelated patients suffering from HD (mean age at onset 40.1 years, range 20–65) we determined number of CAG repeats and the distribution of the APOE alleles (ɛ2, ɛ3, ɛ4) and PS-1 alleles. The results showed that: (a) The age at onset was higher in the group of patients with the ɛ4 allele (51.6 vs. 38.0 P < 0.002), (b) The correlation between the age at onset and the number of CAG repeats was strong in patients with the ɛ3/ɛ3 genotype while it was not detected in patients with ɛ3/ɛ4 genotype. (c) No correlation was found between age at onset and PS-1 alleles. In conclusion, APOE seems to be a significant factor influencing the age at onset of Huntington’s disease.


American Journal of Medical Genetics | 2000

Association between presenilin-1 polymorphism and maternal meiosis II errors in Down syndrome.

Michael B. Petersen; Georgia Karadima; Maria Samaritaki; Dimitris Avramopoulos; Dimitris Vassilopoulos; Margareta Mikkelsen

Several lines of evidence suggest a shared genetic susceptibility to Down syndrome (DS) and Alzheimer disease (AD). Rare forms of autosomal-dominant AD are caused by mutations in the APP and presenilin genes (PS-1 and PS-2). The presenilin proteins have been localized to the nuclear membrane, kinetochores, and centrosomes, suggesting a function in chromosome segregation. A genetic association between a polymorphism in intron 8 of the PS-1 gene and AD has been described in some series, and an increased risk of AD has been reported in mothers of DS probands. We therefore studied 168 probands with free trisomy 21 of known parental and meiotic origin and their parents from a population-based material, by analyzing the intron 8 polymorphism in the PS-1 gene. An increased frequency of allele 1 in mothers with a meiosis II error (70.8%) was found compared with mothers with a meiosis I error (52.7%, P < 0.01), with an excess of the 11 genotype in the meiosis II mothers. The frequency of allele 1 in mothers carrying apolipoprotein E (APOE) epsilon4 allele (68.0%) was higher than in mothers without epsilon4 (52.2%, P < 0.01). We hypothesize that the PS-1 intronic polymorphism might be involved in chromosomal nondisjunction through an influence on the expression level of PS-1 or due to linkage disequilibrium with biologically relevant polymorphisms in or outside the PS-1 gene.


Psychiatric Genetics | 2003

Genetic association between the phospholipase A2 gene and unipolar affective disorder: A multicentre case-control study

George N. Papadimitriou; Dimitris Dikeos; Daniel Souery; Jurgen Del-Favero; Isabelle Massat; Dimitrios Avramopoulos; Sylvie Blairy; S. Cichon; Sladjana Ivezic; Radka Kaneva; Georgia Karadima; Roberta Lilli; Vihra Milanova; Markus M. Nöthen; Lilijana Oruč; Marcella Rietschel; Alessandro Serretti; Christine Van Broeckhoven; Costas N. Stefanis; Julien Mendlewicz

The co-segregation in one pedigree of bipolar affective disorder with Dariers disease whose gene is on chromosome 12q23-q24.1, and findings from linkage and association studies with the neighbouring gene of phospholipase A2 (PLA2) indicate that PLA2 may be considered as a candidate gene for affective disorders. All relevant genetic association studies, however, were conducted on bipolar patients. In the present study, the possible association between the PLA2 gene and unipolar affective disorder was examined on 321 unipolar patients and 604 controls (all personally interviewed), recruited from six countries (Belgium, Bulgaria, Croatia, Germany, Greece, and Italy) participating in the European Collaborative Project on Affective Disorders. After controlling for population group and gender, one of the eight alleles of the investigated marker (allele 7) was found to be more frequent among unipolar patients with more than three major depressive episodes than among controls (P<0.01); genotypic association was also observed, under the dominant model of genetic transmission (P<0.02). In addition, presence of allele 7 was correlated with a higher frequency of depressive episodes (P<0.02). These findings suggest that structural variations at the PLA2 gene or the chromosomal region around it may confer susceptibility for unipolar affective disorder.


American Journal of Medical Genetics | 2000

Molecular cytogenetic characterization and origin of two de novo duplication 9p cases

Aspasia Tsezou; Sofia Kitsiou; Angeliki Galla; Michael B. Petersen; Georgia Karadima; Maria Syrrou; Sigrid Sahlén; Elisabeth Blennow

We report on two additional cases with duplication of 9p, minor with facial anomalies and developmental delay. Using fluorescence in situ hybridization and single-copy probes, we showed that the first case was a direct duplication, whereas the second case was inverted. The extent of the direct duplication was defined as 9p12 --> p24 by microdissection and microcloning of the aberrant chromosome and subsequent chromosome-specific comparative genomic hybridization. DNA polymorphism analysis with eight microsatellite markers revealed that the origin of the dup(9p) was maternal in the first case, whereas it was paternal in the second.


Neuropsychobiology | 2001

Association between GABA-A Receptor Alpha 5 Subunit Gene Locus and Schizophrenia of a Later Age of Onset

George N. Papadimitriou; Dimitris Dikeos; Eugenia Daskalopoulou; Georgia Karadima; Dimitrios Avramopoulos; Costas Contis; Costas N. Stefanis

Heritability is considered to be a major etiologic factor for schizophrenia. Among the genes considered as candidates for the disease, are those related to GABAergic neurotransmission. Our aim was to test for a genetic association between GABA-A receptor alpha 5 subunit gene locus (GABRA5) and schizophrenia. Genotyping of the GABRA5 locus was performed by the use of a dinucleotide (CA) repeat marker in 46 schizophrenic patients and 50 healthy individuals, all unrelated Greeks. Eight alleles were identified, 276–290 bp long. A nonsignificant excess of the 282-bp allele, which was found in a previous study in a Greek population to be associated with bipolar affective disorder, was observed in schizophrenic patients (33.8 vs. 23.9% in the controls). The frequency of this allele was 43.3% among patients with a later age of onset (over 25 years), differing at a statistically significant level from the controls (p < 0.05). These results suggest that common pathophysiological mechanisms may possibly underlie affective disorders and schizophrenia, at least in a subgroup of patients.


European Journal of Human Genetics | 2016

Hereditary spastic paraplegia in Greece: characterisation of a previously unexplored population using next-generation sequencing.

David S. Lynch; Georgios Koutsis; Arianna Tucci; Marios Panas; Markella Baklou; Marianthi Breza; Georgia Karadima; Henry Houlden

Hereditary Spastic Paraplegia (HSP) is a syndrome characterised by lower limb spasticity, occurring alone or in association with other neurological manifestations, such as cognitive impairment, seizures, ataxia or neuropathy. HSP occurs worldwide, with different populations having different frequencies of causative genes. The Greek population has not yet been characterised. The purpose of this study was to describe the clinical presentation and molecular epidemiology of the largest cohort of HSP in Greece, comprising 54 patients from 40 families. We used a targeted next-generation sequencing (NGS) approach to genetically assess a proband from each family. We made a genetic diagnosis in >50% of cases and identified 11 novel variants. Variants in SPAST and KIF5A were the most common causes of autosomal dominant HSP, whereas SPG11 and CYP7B1 were the most common cause of autosomal recessive HSP. We identified a novel variant in SPG11, which led to disease with later onset and may be unique to the Greek population and report the first nonsense mutation in KIF5A. Interestingly, the frequency of HSP mutations in the Greek population, which is relatively isolated, was very similar to other European populations. We confirm that NGS approaches are an efficient diagnostic tool and should be employed early in the assessment of HSP patients.


Journal of Neurology | 2002

Friedreich's ataxia mimicking hereditary motor and sensory neuropathy

Marios Panas; Nikolaos Kalfakis; Georgia Karadima; Panagiota Davaki; Demetris Vassilopoulos

Abstract. Four patients from three unrelated families, with clinical and electrophysiological findings compatible with the diagnosis of hereditary motor and sensory neuropathy, are presented. The molecular analysis showed that the affected individuals were homozygous for the mutation in the X25 gene, characteristic of Friedreichs ataxia. These patients seem to represent a form of Friedreichs ataxia mimicking Charcot-Marie-Tooth disease.


Journal of Neurology | 2000

Genotyping of presenilin-1 polymorphism in amyotrophic lateral sclerosis.

Marios Panas; Georgia Karadima; Nikolaos Kalfakis; Ourania Psarrou; Paraskevi Floroskoufi; Athina Kladi; Michael B. Petersen; Demetris Vassilopoulos

Abstract The mechanisms underlying motor neuron degeneration in amyotrophic lateral sclerosis are not fully understood. Recent studies suggest that apoptosis is involved in the abnormal neural death that occurs in this devastating disease. Presenilin-1, a transmembrane protein, seems to be implicated in apoptosis. To determine whether presenilin-1 intron 8 polymorphism has an influence in the course of amyotrophic lateral sclerosis, we examined this polymorphism genotypes in a large group of patients (n=72) with amyotrophic lateral sclerosis and in a random sample of 213 healthy individuals. The results showed a significant difference in genotype (P < 0.04) and allele (P < 0.03) distribution between patients and controls. These results suggest a possible intervention of presenilin-1 in the pathogenesis of amyotrophic lateral sclerosis.

Collaboration


Dive into the Georgia Karadima's collaboration.

Top Co-Authors

Avatar

Marios Panas

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Georgios Koutsis

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Dimitris Dikeos

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

George N. Papadimitriou

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Costas N. Stefanis

Mental Health Research Institute

View shared research outputs
Top Co-Authors

Avatar

Demetris Vassilopoulos

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Nikolaos Kalfakis

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Dimitrios Avramopoulos

Mental Health Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge